...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Trial

My guess is this one:

American Association for Cancer Research 2020 meeting in San Diego end of April. https://www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=213

Share
New Message
Please login to post a reply